EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Lactate reprograms glioblastoma immunity through CBX3-regulated histone lactylation

Shuai Wang, Tengfei Huang, Qiulian Wu, Huairui Yuan, Xujia Wu, Fanen Yuan, Tingting Duan, Suchet Taori, Yingming Zhao, Nathaniel W Snyder, Dimitris G Placantonakis, Jeremy N Rich

Journal of Clinical Investigation · 15.11.2024 · 134 (22)

DOI: 10.1172/jci176851 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Investigation, online erschienen am 15.11.2024. Verfasst von Shuai Wang und 11 weiteren Autor:innen. Beteiligte Einrichtung: Hillman Cancer Center and Department of Neurology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA. Hauptthemen laut MEDLINE: Glioblastoma, Histones, Lactic Acid. Die Arbeit wurde bisher 148-mal zitiert (Crossref) und nennt 85 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NINDS NIH HHS, NCI NIH HHS, NIGMS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Glioblastoma (GBM), an aggressive brain malignancy with a cellular hierarchy dominated by GBM stem cells (GSCs), evades antitumor immunity through mechanisms that remain incompletely understood. Like most cancers, GBMs undergo metabolic reprogramming toward glycolysis to generate lactate. Here, we show that lactate production by patient-derived GSCs and microglia/macrophages induces tumor cell epigenetic reprogramming through histone lactylation, an activating modification that leads to immunosuppressive transcriptional programs and suppression of phagocytosis via transcriptional upregulation of CD47 , a “don’t eat me” signal, in GBM cells. Leveraging these findings, pharmacologic targeting of lactate production augments efficacy of anti-CD47 therapy. Mechanistically, lactylated histone interacts with the heterochromatin component chromobox protein homolog 3 (CBX3). Although CBX3 does not possess direct lactyltransferase activity, CBX3 binds histone acetyltransferase (HAT) EP300 to induce increased EP300 substrate specificity toward lactyl-CoA and a transcriptional shift toward an immunosuppressive cytokine profile. Targeting CBX3 inhibits tumor growth by both tumor cell–intrinsic mechanisms and increased tumor cell phagocytosis. Collectively, these results suggest that lactate mediates metabolism-induced epigenetic reprogramming in GBM that contributes to CD47-dependent immune evasion, which can be leveraged to augment efficacy of immuno-oncology therapies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GlioblastomaHistonesLactic AcidHumansMiceAnimalsBrain NeoplasmsCell Line, TumorNeoplastic Stem CellsNeoplasm ProteinsEpigenesis, GeneticCD47 AntigenChromosomal Proteins, Non-Histone

Stichwörter der Autor:innen

Adult stem cellsBrain cancerEpigeneticsMetabolismOncology

Substanzen

HistonesCBX3 protein, humanLactic AcidNeoplasm ProteinsCD47 AntigenChromosomal Proteins, Non-Histone

Autor:innen und Institutionen

  • Hillman Cancer Center and Department of Neurology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA.
  • Department of Neurosurgery and Perlmutter Cancer Center, NYU Grossman School of Medicine, New York, New York, USA.
  • School of Medicine, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA.
  • Ben May Department for Cancer Research, The University of Chicago, Chicago, Illinois, USA.
  • Department of Cardiovascular Sciences, Lewis Katz School of Medicine at Temple University, Philadelphia, Pennsylvania, USA.

Förderung

  • NINDS NIH HHS
  • NCI NIH HHS
  • NIGMS NIH HHS
  • NIAMS NIH HHS
  • National Institutes of Health
  • Defense Health Agency

Zitieren

APA

Wang, S., Huang, T., Wu, Q., Yuan, H., Wu, X., Yuan, F., Duan, T., Taori, S., Zhao, Y., Snyder, N. W., Placantonakis, D. G., & Rich, J. N. (2024). Lactate reprograms glioblastoma immunity through CBX3-regulated histone lactylation. Journal of Clinical Investigation, 134(22). https://doi.org/10.1172/jci176851

Vancouver

Wang S, Huang T, Wu Q, Yuan H, Wu X, Yuan F, et al. Lactate reprograms glioblastoma immunity through CBX3-regulated histone lactylation. Journal of Clinical Investigation. 2024;134(22). doi:10.1172/jci176851

BibTeX
@article{Wang2024,
  author = {Wang, Shuai and Huang, Tengfei and Wu, Qiulian and Yuan, Huairui and Wu, Xujia and Yuan, Fanen and Duan, Tingting and Taori, Suchet and Zhao, Yingming and Snyder, Nathaniel W and Placantonakis, Dimitris G and Rich, Jeremy N},
  title = {Lactate reprograms glioblastoma immunity through CBX3-regulated histone lactylation},
  journal = {Journal of Clinical Investigation},
  year = {2024},
  volume = {134},
  number = {22},
  doi = {10.1172/jci176851}
}
Kostenlos starten →